Get the Stockscreener App
3.13
0.00%
0.41
Nephros Inc stock is traded at $3.13, with a volume of 51,893.
It is up +0.00% in the last 24 hours and up +43.51% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$2.72
Open:
$2.87
24h Volume:
51,893
Relative Volume:
3.52
Market Cap:
$33.18M
Revenue:
$13.55M
Net Income/Loss:
$-929.00K
P/E Ratio:
-34.78
EPS:
-0.09
Net Cash Flow:
$-2.09M
1W Performance:
-6.85%
1M Performance:
+43.51%
6M Performance:
+68.94%
1Y Performance:
+24.77%
1-Day Range:
$2.87
$3.418
1-Week Range:
$2.28
$3.418
52-Week Range:
$1.3643
$3.418
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 1.84 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.00 | 634.81M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.35 | 372.90M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
11.50 | 196.31M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.52 | 128.76M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1561 | 337.87M | 2.07B | -1.42B | -1.37B | -0.6765 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros Announces Upcoming Virtual Analyst and Investor Event to Discuss Water Technology Innovations - citybuzz -
Nephros (NASDAQ:NEPH) Trading 16.4% Higher – What’s Next? - Defense World
NEPH stock touches 52-week high at $2.43 amid market optimism - Investing.com Australia
NEPH stock touches 52-week high at $2.43 amid market optimism By Investing.com - Investing.com South Africa
Nephros, Inc. Reports Strong Q1 2025 Financial Results - TipRanks
NEPHROS INC SEC 10-Q Report - TradingView
Should You Think About Buying Nephros, Inc. (NASDAQ:NEPH) Now? - simplywall.st
Nephros First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Nephros Reports Strong Q1 2025 Financial Performance with 38% Revenue Increase - citybuzz -
What To Expect From Nephros Inc (NEPH) Q1 2025 Earnings - Yahoo Finance
Nephros (NEPH) Expected to Announce Quarterly Earnings on Thursday - Defense World
Nephros Schedules First Quarter 2025 Financial Results Conference Call - The Globe and Mail
Nephros Board Member Alisa Lask to Step Down - TipRanks
Nephros expands filtration line with new S100 In-Line filter - Investing.com Australia
Nephros expands filtration line with new S100 In-Line filter By Investing.com - Investing.com India
Investors Still Aren't Entirely Convinced By Nephros, Inc.'s (NASDAQ:NEPH) Revenues Despite 32% Price Jump - simplywall.st
April 2025's Top Penny Stocks To Consider - simplywall.st
Nephros Announces Financial Results for Quarter Ended March 31, 2025 - The Globe and Mail
Nephros Full Year 2024 Earnings: Beats Expectations - Yahoo Finance
Aethlon Medical (NASDAQ:AEMD) & Nephros (NASDAQ:NEPH) Head to Head Comparison - Defense World
Nephros, Inc. (NASDAQ:NEPH) Sees Significant Drop in Short Interest - Defense World
NEPHROS INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus.com
Nephros, Inc. Reports First Profitable Year - TipRanks
Earnings call transcript: Nephros Q4 2024 beats EPS forecast, stock surges - Investing.com Australia
Earnings call transcript: Nephros Q4 2024 beats EPS forecast, stock surges By Investing.com - Investing.com South Africa
Nephros Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Nephros earnings beat by $0.05, revenue topped estimates - Investing.com Canada
Nephros Inc (NEPH) Q4 Earnings: EPS of $0.02 Beats Estimate, Rev - GuruFocus.com
Nephros, Inc. Reports Fourth Quarter and Fiscal Year 2024 Financial Results - TradingView
Nephros Announces Fourth Quarter and Fiscal Year 2024 Financial Results -March 06, 2025 at 04:11 pm EST - Marketscreener.com
Earnings To Watch: Nephros Inc (NEPH) Reports Q4 2024 Result - GuruFocus.com
Nephros Amends CFO Employment Terms for Strategic Growth - TipRanks
Nephros Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Nephros, Inc. to Host Earnings Call - ACCESS Newswire
Nephros (NEPH) Projected to Post Earnings on Thursday - Defense World
Nephros Sets Date for Q4 and Fiscal Year 2024 Financial Results Presentation - citybuzz -
Nephros Announces Submission of Special 510(k) Application to the FDA for the EndoPur(TM) Ultrafilter - ACCESS Newswire
Nephros (NASDAQ:NEPH) and Sintx Technologies (NASDAQ:SINT) Head to Head Analysis - Defense World
Nephros (NASDAQ:NEPH) Trading 1.3% Higher – Should You Buy? - Defense World
Insider Buyers Lose US$47k As Nephros Sheds US$2.0m - Simply Wall St
Nephros (FRA:NPJP) Forward Dividend Yield % : 0.00% (As of Jan. 16, 2025) - GuruFocus.com
Analysts Expect Nephros, Inc. (NASDAQ:NEPH) To Breakeven Soon - Yahoo Finance
Nephros, Inc. (NASDAQ:NEPH) Q3 2024 Earnings Call Transcript - MSN
Critical Analysis: Todos Medical (OTCMKTS:TOMDF) and Nephros (NASDAQ:NEPH) - Defense World
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks - Simply Wall St
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Nephros to Participate in the Benchmark Company Annual Discovery One-on-One Investor Conference on December 11, 2024 in NYC - The Manila Times
Nephros to Present at Benchmark's Discovery Investor Conference, CEO and CFO to Meet Key Investors - StockTitan
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.04%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):